Position Paper Highlights Advancements in Balance Enclosure Technology
Labconco Corporation offers an 8-page white paper titled, "Advances in Balance Enclosure Technology Bring Safety Enhancements to the Pharmaceutical Industry."
The paper describes the evolution of prescription drug development and how pharmaceutical, biotechnology, chemical and healthcare companies are trying to identify new compounds that will become the drugs of tomorrow. Containment solutions for reducing worker exposure during weighing and dispensing of hazardous powders are now in the forefront. Use of traditional fume hoods and their shortcomings to contain powders are discussed and compared to balance enclosures, stations and systems which were introduced into the marketplace in the early 1990's. One balance enclosure advancement, the XPert® Balance Enclosure, is presented in detail.
Independent testing to validate the containment of the XPert Balance Enclosure is provided. ASHRAE 110-1995 testing, conducted by ECT, Incorporated, Cary, North Carolina, concluded that the XPert Balance Enclosure maintained containment of tracer gas at face velocities greater than 50 fpm.
An industrial hygiene air-monitoring study, conducted by SafeBridge Consultants, Inc., Mountain View, California, confirmed the XPert Balance Enclosure's ability to effectively contain naproxen sodium, a non-potent active pharmaceutical ingredient selected for its high dustiness quotient and challenging electrostatic properties.
To download the white paper, visit www.labconco.com, or call Labconco at (800) 732-0031.
